Allergy Therapeutics (LSE:AGY) Change In Other Working Capital : £9.40 Mil (TTM As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Allergy Therapeutics Change In Other Working Capital?

Allergy Therapeutics's Change In Other Working Capital for the quarter that ended in Dec. 2023 was £3.17 Mil. It means Allergy Therapeutics's Other Working Capital increased by £3.17 Mil from Jun. 2023 to Dec. 2023 .

Allergy Therapeutics's Change In Other Working Capital for the fiscal year that ended in Jun. 2023 was £4.82 Mil. It means Allergy Therapeutics's Other Working Capital increased by £4.82 Mil from Jun. 2022 to Jun. 2023 .

Allergy Therapeutics Change In Other Working Capital Historical Data

The historical data trend for Allergy Therapeutics's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Change In Other Working Capital Chart

Allergy Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Change In Other Working Capital

Get a 7-Day Free Trial

0.16

-2.40

0.55

-1.07

4.82

Allergy Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Other Working Capital	Get a 7-Day Free Trial															-1.39	0.32	-1.41	6.22	3.17

Allergy Therapeutics Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £9.40 Mil.

Allergy Therapeutics Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (LSE:AGY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (LSE:AGY) » Definitions » Change In Other Working Capital

Comparable Companies

Traded in Other Exchanges

HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

https://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergies with aluminum-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (LSE:AGY) Headlines

No Headlines